Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-078643
Filing Date
2025-08-14
Accepted
2025-08-14 16:20:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 15562
2 EXHIBIT 99.1 tm2523440d1_ex99-1.htm EX-99.1 5864
  Complete submission text file 0001104659-25-078643.txt   23008
Mailing Address C/O VINIK ASSET MANAGEMENT LP 260 FRANKLIN STREET, SUITE 1900 BOSTON MA 02110
Business Address
GORDON MICHAEL S (Filed by) CIK: 0001034608 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Subject) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93797 | Film No.: 251219564
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)